Risk score model to predict outcome after allogeneic stem cell transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukaemia. A report from the MDS subcommittee of the Chronic Leukemia Working Party of the EBMT

被引：0
|
作者：
Kroeger, N.
Brand, R.
van Biezen, A.
Zander, A.
Dierlamm, J.
Niederwieser, D.
Devergie, A.
Ruutu, T.
Cornish, J.
van der Borne, P.
Ljungman, P.
Gratwohl, A.
Cordonnier, C.
Beelen, D.
Deconinck, E.
Symeonidis, A.
De Witte, T.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [1] Allogeneic stem cell transplantation for therapy-related myelodysplastic syndrome (t-MDS) and acute myeloid leukemia. A report from the MDS subcommittee of the chronic leukemia working party of the European group for blood and marrow transplantation (EBMT)
    Kroeger, Nicolaus
    Brand, Ronald
    van Biezen, Anja
    Niederwieser, Dietger
    de Witte, Theo
    BLOOD, 2007, 110 (11) : 81A - 81A
  • [2] Allogeneic stem cell transplantation for therapy-related Myelodysplastic Syndrome (T-MDS) and acute myeloid leukemia (T-AML).: A report from the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    Kroeger, N.
    ANNALS OF HEMATOLOGY, 2008, 87 : S3 - S3
  • [3] IMPACT OF CYTOGENETIC ABNORMALITIES ON OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR THERAPY-RELATED MYELODYSPLASTIC SYNDROME (T-MDS) AND ACUTE MYELOID LEUKEMIA. A REPORT FROM THE MDS SUBCOMMITTEE OF THE CHRONIC LEUKEMIA WORKING PARTY OF THE EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATI
    Kroeger, N.
    Brand, R.
    Van Biezen, A.
    Zander, A.
    Dierlamm, J.
    Niederwieser, D.
    Devergie, A.
    Trapani, R.
    Cornish, J.
    Van der Borne, P.
    Ljungman, P.
    Gratwohl, A.
    Cordonnier, C.
    Beelen, D.
    Deconinck, E.
    Symoneidis, A.
    De Witte, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 361 - 362
  • [4] Management and outcome of myelodysplastic syndrome (MDS) and secondary acute myeloid leukaemia relapsing after allogeneic stem cell transplantation - A retrospective analysis on 888 patients by the MDS Subcommittee of the EBMT Chronic Leukaemia Working Pa
    Schmid, C.
    van Biezen, A.
    Brand, R.
    Finke, J.
    Volin, L.
    Vitek, A.
    Selleslag, D.
    Heim, D.
    van dem Borne, P.
    Ganser, A.
    Mohty, M.
    Boogaerts, M.
    de Witte, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S62 - S63
  • [5] Outcome of allogeneic HSCT for patients transformed from aplastic anaemia to MDS or leukaemia. A report by the MDS subcommittee of the Chronic Leukaemia Working Party and the Aplastic Anaemia Working Party of the EBMT
    Passweg, J.
    Socie, G.
    Tichelli, A.
    Borne, P. A. von Dem
    Schattenberg, A.
    Foa, R.
    Ganser, A.
    Dufour, C.
    Bacigalupo, A.
    Locasciulli, A.
    Aljurf, M.
    Peters, C.
    van Biezen, A.
    de Witte, T.
    Marsh, J.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S83 - S83
  • [6] Relapse risk score after allogeneic stem cell transplantation for MDS patients. An EBMT study from the MDS subcommittee of Chronic Malignancies Working Party (CMWP)
    Kroeger, N.
    Putter, H.
    de Wreede, L.
    van Biezen, A.
    Ziagkos, D.
    Volin, L.
    Maertens, J.
    Finke, J.
    Ljungman, P.
    Russell, N.
    Yakoub-Agha, I.
    Schaap, M.
    Craddock, C.
    Mufti, G.
    Chevallier, P.
    Passweg, J.
    Milpied, N.
    Blaise, D.
    Bourhis, J. H.
    Gedde-Dahl, T.
    Espiga, C. R.
    Cornelissen, J.
    Goehring, G.
    Schetelig, J.
    de Witte, T.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S310 - S311
  • [7] Relapse Risk Score after Allogeneic Stem Cell Transplantation for MDS Patients. an EBMT Study from the MDS Subcommittee of Chronic Malignancies Working Party (CMWP)
    Kroger, Nicolaus
    Putter, Hein
    De Wreede, Liesbeth
    van Biezen, Anja
    Ziagkos, Dimitris
    Volin, Liisa
    Maertens, Johan
    Finke, Jurgen
    Ljungman, Per T.
    Russell, Nigel H.
    Yakoub-Agha, Ibrahim
    Schaap, Michel
    Craddock, Charles
    Mufti, Ghulam J.
    Chevallier, Patrice
    Passweg, Jakob R.
    Milpied, Noel
    Blaise, Didier
    Bourhis, Jean-Henri
    Gedde-Dahl, Tobias
    Espiga, Carlos Richard
    Cornelissen, Jan J.
    Gohring, Gudrun
    Schetelig, Johannes
    de Witte, Theo
    Robin, Marie
    BLOOD, 2016, 128 (22)
  • [8] Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation
    Kroeger, Nicolaus
    Brand, Ronald
    van Biezen, Anja
    Zander, Axel
    Dierlamm, Judith
    Niederwieser, Dietger
    Devergie, Agnes
    Ruutu, Tapani
    Cornish, Jackie
    Ljungman, Per
    Gratwohl, Alois
    Cordonnier, Catherine
    Beelen, Dietrich
    Deconinck, Eric
    Symeonidis, Argiris
    de Witte, Theo
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (04): : 542 - 549
  • [9] Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: A propensity score matched analysis
    Itonaga, Hidehiro
    Kida, Michiko
    Hamamura, Atsushi
    Uchida, Naoyuki
    Ozawa, Yukiyasu
    Fukuda, Takahiro
    Ueda, Yasunori
    Kataoka, Keisuke
    Katayama, Yuta
    Ota, Shuichi
    Matsuoka, Ken-ichi
    Kondo, Tadakazu
    Eto, Tetsuya
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Miyazaki, Yasushi
    Ishiyama, Ken
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 752 - 762
  • [10] Outcome of chronic myeloid leukaemia patients with allogeneic haematopoietic stem cell transplantation and a low risk score in the imatinib era. A report from the EBMT Chronic Leukemia Working Party and the European Leukemia Net
    Heim, D.
    Brand, R.
    Olavarria, E.
    Apperley, J. F.
    Crawley, C.
    Devergie, A.
    Aljurf, A.
    Holowiecki, J.
    Ruutu, T.
    Brinch, L.
    Kolb, H. J.
    de Witte, T.
    Hehlmann, R.
    Gratwohl, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S37 - S37
12345